Search

everythinglearnresearchcommunity

for

Search:↓

Dexamethasone mini-pulse therapy is effective for alopecia areata but less effective for those with early onset or hypothyroidism.

2.5 mg/mL TAC is as effective and safe as 5 mg/mL, but 5 mg/mL may improve hair regrowth and density more.

Hinokitiol may help treat hair loss by reducing inflammation and promoting hair growth.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

Synthetic hormone treatment reduces melanin and hair growth in rats.

TSC2-/meth cells can cause skin lesions, hair growth, and lung issues, and may be treated with chromatin remodeling agents.

Correcting selenium and zinc levels may help manage hair loss in autoimmune thyroiditis.

Fenoterol treatment causes increased hair growth due to higher metabolism in hair follicles, not hormones.

Vitamin D may help reduce thyroid antibodies and improve thyroid function in Hashimoto's Thyroiditis.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

The study suggests that hypothyroidism may cause alopecia areata.

The TRPV3 gene mutation affects hair growth by keeping mice in the growth phase longer, which could help treat hair loss.

Higher thyroid hormone levels may be linked to certain types of polycystic ovary syndrome.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Testosterone replacement therapy improves libido, mood, muscle strength, and bone density in men with Testosterone Deficiency Syndrome.

Hormone replacement therapy may improve hair growth in the frontal hairline of postmenopausal women with hair loss.

The study found a specific peptide that helps detect TGase 3 activity in skin and hair follicles.

Oral testosterone therapy raises heart risk more than other methods.

Tiger tail banding and hair abnormalities are reliable indicators for diagnosing trichothiodystrophy.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Trichoriboside treatment helps maintain scalp hair by increasing cAMP levels in hair follicles of men with hair loss.

Thymosin beta 4 protects cells from damage by blocking a harmful microRNA and boosting a protective gene.

Hormonal imbalances, including high prolactin and thyroid issues, contribute to hair growth problems in women.

Topical calcitriol appears safe and may reduce hair loss during chemotherapy.

Retinoic acid, glucocorticoids, and IGF1 increase IGFBP-3 production in human dermal papilla cells, affecting hair growth.